Managing Oesophageal Disease in Systemic Sclerosis

Systemic sclerosis can affect the oesophagus early, even when skin or lung symptoms dominate the clinical picture. Smooth-muscle atrophy, fibrosis and impaired lower oesophageal sphincter function may produce reflux, dysphagia, regurgitation, chest discomfort and nocturnal cough. A structured approach helps distinguish reflux injury from motility failure, stricture and aspiration.

For Australian clinicians, management often involves a rheumatologist, gastroenterologist, speech pathologist, dietitian and pharmacist. Coordination matters across metropolitan services in Sydney, Melbourne, Brisbane and Perth, as well as for patients travelling long distances from regional and remote communities.

The educational material associated with the ISDE congress reflects the value of multidisciplinary discussion in complex oesophageal disease. Clinicians reviewing historical congress resources can also find practical registration information alongside scientific sessions and specialist presentations.

Recognising the oesophageal pattern

Heartburn and acid regurgitation are common, but symptoms may be atypical. Patients can report food sticking, prolonged mealtimes, cough after swallowing, recurrent chest infections or difficulty taking tablets. Early satiety and weight loss may reflect gastrointestinal involvement rather than simple dietary restriction.

A careful history should cover solids versus liquids, postural symptoms, nocturnal episodes, dental erosion and aspiration risk. Australian eating habits, including frequent takeaway meals, large evening meals and alcohol consumption at social events, can aggravate reflux. Ask about smoking, coffee, carbonated drinks and medications that may injure the mucosa or impair motility.

Confirming reflux and motility impairment

Upper endoscopy is useful when dysphagia, anaemia, weight loss, bleeding or persistent symptoms are present. It can identify erosive oesophagitis, Barrett’s oesophagus, candidiasis and peptic stricture. Biopsies should be guided by the endoscopic appearance and clinical differential diagnosis.

High-resolution manometry remains central when symptoms persist despite acid suppression or when dysphagia is prominent. Typical findings include absent or weak peristalsis and a hypotensive lower oesophageal sphincter. Ambulatory pH or impedance monitoring can clarify ongoing acid or non-acid reflux when endoscopy is normal or treatment decisions are uncertain.

Building an acid suppression strategy

A proton pump inhibitor is usually the foundation for reflux-related symptoms and mucosal protection. The dose should be taken correctly, commonly before food, and adherence should be checked before escalating therapy. If response is incomplete, clinicians may review timing, increase dosing when appropriate or consider an H2-receptor antagonist for selected nocturnal symptoms.

Prescribing should account for the Australian market, Pharmaceutical Benefits Scheme restrictions and the patient’s medication burden. Long-term therapy warrants periodic review rather than automatic continuation. Indications, symptom control, adverse effects and the need for surveillance should be documented clearly, particularly when care is shared between public hospitals and general practice.

Supporting swallowing and nutrition

Small, frequent meals, thorough chewing and remaining upright after eating can reduce regurgitation. Patients may benefit from softer textures, added moisture and alternating food with sips of fluid. They should avoid lying down for several hours after the evening meal and consider elevating the head of the bed rather than relying only on extra pillows.

A dietitian can protect nutritional status when dysphagia or early satiety limits intake. A speech pathologist can assess swallowing safety if coughing, wet voice or recurrent chest infections suggest aspiration. In rural Australia, telehealth reviews can support local clinicians, while practical plans should account for availability and cost of texture-modified foods.

Addressing strictures and aspiration

Progressive solid-food dysphagia may indicate a peptic stricture and requires timely endoscopic assessment. Dilatation can improve passage, but recurrence is more likely if reflux remains uncontrolled. Persistent or recurrent narrowing should prompt reassessment for inflammation, malignancy and alternative causes.

Aspiration prevention includes upright positioning, slower eating and review of swallowing technique. Night-time regurgitation deserves particular attention because microaspiration can worsen cough, bronchiectasis or interstitial lung disease. Any new respiratory decline should be assessed with the patient’s respiratory and rheumatology teams rather than attributed automatically to systemic sclerosis.

Considering medicines and advanced options

Prokinetic treatment may help selected patients with troublesome gastric emptying or reflux, but benefits and adverse effects vary. Domperidone use requires attention to cardiac risk and Australian prescribing requirements, while metoclopramide is generally limited by neurological adverse effects and duration concerns. Medication decisions should be individualised and reviewed by a clinician familiar with the patient’s comorbidities.

Antireflux surgery is approached cautiously because severe oesophageal dysmotility can lead to postoperative dysphagia. Specialist assessment is essential, with objective reflux testing and manometry informing selection. In carefully chosen cases, alternative procedures may be considered, but surgery does not correct the underlying smooth-muscle failure.

Practical management priorities

A coordinated plan can reduce complications and make follow-up more consistent. The following measures are useful in routine Australian practice:

• Document dysphagia characteristics, weight trend and aspiration symptoms at each review.
• Optimise proton pump inhibitor timing and reassess the indication for long-term treatment.
• Arrange endoscopy promptly for alarm symptoms, bleeding, anaemia or progressive dysphagia.
• Use manometry and reflux monitoring when symptoms persist or the diagnosis remains uncertain.
• Refer to a dietitian and speech pathologist when intake, swallowing safety or nutrition is affected.
• Consider rural access, PBS supply, transport and telehealth when designing follow-up.
• Escalate new respiratory symptoms promptly, especially in patients with interstitial lung disease.

Maintaining long-term surveillance

Symptoms can fluctuate, while oesophageal injury progresses silently. Follow-up should review reflux control, swallowing, nutritional status, respiratory symptoms and medication safety. Barrett’s oesophagus, strictures and recurrent candida infection require management according to standard gastroenterology pathways.

Patients should receive clear written advice about red flags, including food impaction, vomiting blood, black stools, rapidly worsening dysphagia, dehydration and unexplained weight loss. Australian privacy obligations and shared-care arrangements also make accurate, accessible documentation important when information moves between general practice, specialist clinics and hospital services.

For patients with systemic sclerosis, successful care combines symptom control with prevention of aspiration, malnutrition and mucosal complications. In practical terms, that means taking acid suppression correctly, modifying meals and posture, investigating progressive swallowing difficulty early, and arranging coordinated review before a manageable problem becomes an emergency.